Metformin (Matee (850 mg)) is an oral antidiabetic agent, prescribed for type 2 diabetes. It helps control blood sugar levels. The information provided on this page is intended to serve as a ...
Please provide your email address to receive an email when new articles are posted on . In adults with prediabetes, metformin and lifestyle interventions decreased the likelihood of type 2 diabetes ...
March 22, 2012 — Long-term treatment with metformin is safe for preventing or delaying the development of type 2 diabetes, according to an article published in the April issue of Diabetes Care. New ...
In the largest investigation into the issue to date, metformin did not improve survival of patients with high-risk, operable breast cancer when added to standard adjuvant treatments. These findings ...
Among adults who lost at least 5% of baseline body weight in the first year of the landmark Diabetes Prevention Program study, those who were assigned to metformin therapy maintained greater weight ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Use ...
Patients undergoing glucocorticoid treatment are at risk of developing metabolic adverse effects, such as the metabolic syndrome. Preclinical studies have suggested that metformin can prevent these ...
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...
For women with recurrent or late-stage endometrial cancer, including metformin as part of a standard chemotherapy regimen offered no additional benefit, a phase II/III study indicated. In the trial of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results